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Introduction
Neonatal lupus erythematosus (NLE) is a rare acquired
autoimmune disease, characterized by the transplacental
passage of maternal antibodies (anti-SSA/Ro and/or
anti-SSB/La) into the fetal circulation system, inducing
clinical manifestation in the neonate. The most serious
clinical manifestation of NLE is a nonreversible com-
plete congenital heart block (CHB), and other common
manifestation included skin rash, hepatobiliary and
hematologic abnormalities, which are usually reversible.
Objectives
Central nervous system involvement is not uncommon,
but up to now there have been no reports of inner ear
involvement in NLE.
Methods
We describe the clinical case of a 13-year-old Caucasian
boy, born from mother with Sjögren syndrome and anti-
SSA/Ro antibodies, who developed a complete congenital
heart block (CHB), treated with pacemaker implantation
at birth. No other clinical manifestations were present in
the perinatal period, and anti-SSA/Ro antibodies positivity
disappeared in the first 6 months of life.
Results
When 12-year-old he developed nausea, nystagmus,
dizziness, tinnitus, vertigo, and hearing loss, so he was
admitted in a community hospital, where laboratory
test revealed leucocytosis, with normal CRP and ESR.
Cultures for bacteria and viruses from blood, throat,
and urine were all negative. Cardiological evaluation
showed a normal heart rate induced by pacemaker;
neurological examination, Brainstem Auditory Evoked
Potentials (BAEPs) and brain CTscan were negative.
ENT evaluation revealed a moderate right sensorineural
hearing loss (SNHL). Initially a diagnosis of labyrinthitis
was made, and a treatment with oral prednisolone
(1 mg/kg daily) was started. Nausea, nystagmus, dizziness,
tinnitus and vertigo disappeared in a few days, while a
persistent moderate right SNHL was confirmed in the fol-
lowing ENT evaluations. Ten months later, the boy
referred headache, and dizziness, and was admitted in our
hospital, where audiometry showed a severe right SNHL,
worsened when compared to the previous examination.
Neurological and cardiological evaluations were normal.
Routine laboratory test and inflammatory markers were
normal. The genotype study of GJB2 (connexin-26) and
GJB6 (connexin-30) mutations were negative, so heredi-
tary hearing loss was excluded. The study of NLRP3 gene
mutations was normal, so Muckle-Wells syndrome was
also ruled out. Autoantibodies against inner ear showed a
positivity for anti-reovirus peptide antibodies, and a strong
positivity for anti-peptide 12 (Cogan peptide), anti-Peptide
CD148 and anti-connexin 26 antibodies. The patient was
diagnosed as having autoimmune hearing loss and was
started an oral prednisone (1 mg/kg/day). Headache and
dizness rapidly disappeared, steroids were tapered after
3 months and hearing loss was stable.
Conclusion
The transplacental passage of maternal antibodies, SSA/Ro
and SSB/La, into the fetal circulation system induced
CHB. To our knowledge, the coexistence of congenital
heart block and SNHK has not been previously reported.
Interestingly, the autoantibodies which are able to induce
tissue damage on binding of cell-surface molecules present
on the sensory epithelia of the inner ear and on endothe-
lial cells can cross-react with anti-SSA/Ro. We are
currently investigating the pathogenetic role of anti-Ro in
inner ear damage.
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